1. Home
  2. SYBT vs GENB Comparison

SYBT vs GENB Comparison

Compare SYBT & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stock Yards Bancorp Inc.

SYBT

Stock Yards Bancorp Inc.

HOLD

Current Price

$76.31

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$16.47

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SYBT
GENB
Founded
1904
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
SYBT
GENB
Price
$76.31
$16.47
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$76.00
$23.20
AVG Volume (30 Days)
167.3K
886.0K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
1.81%
N/A
EPS Growth
22.11
N/A
EPS
1.24
N/A
Revenue
$23,406,000.00
N/A
Revenue This Year
$17.31
N/A
Revenue Next Year
$9.32
$16.58
P/E Ratio
$61.17
N/A
Revenue Growth
3.37
N/A
52 Week Low
$61.51
$11.00
52 Week High
$83.83
$17.42

Technical Indicators

Market Signals
Indicator
SYBT
GENB
Relative Strength Index (RSI) 62.64 62.89
Support Level $68.40 $11.73
Resistance Level N/A $16.75
Average True Range (ATR) 1.93 1.02
MACD 0.19 0.36
Stochastic Oscillator 76.42 78.29

Price Performance

Historical Comparison
SYBT
GENB

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: